TY - THES A1 - Hipp, Matthias T1 - Modifikation elektrochemisch auf Titan aufgebrachter Calciumhydroxidbeschichtungen durch Fremdmetallionendotierung T1 - Modification of electrochemically deposited calcium hydroxide surface coatings on titanium by different metal ions N2 - Die Verwendung von im Knochen befestigten Implantaten und Endoprothesen aus Titan, sowie Osteosyntheseverfahren mittels Plattenapplikation stellen häufige Routineeingriffe in der Medizin dar. Die Infektion einer Endoprothese oder Osteosyntheseplatte mit Biofilmbildung bedeutet dabei eine schwerwiegende postoperative Komplikation. Ein Schwerpunkt medizinischer Forschung beschäftigt sich aus diesem Grunde mit der Entwicklung antiseptischer Oberflächen. Die vorliegende Arbeit beschreibt die Weiterentwicklung einer in der Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde der Universitätsklinik Würzburg entwickelten elektrochemischen Calciumhydroxidbeschichtung auf Titan. Durch die gezielte Dotierung der Ausgangsschicht mit Silberionen konnte die starke kurzfristige Antisepsis des Calciumhydroxides mit einer wirksamen und langfristigen bakteriziden Wirkung des Silbers kombiniert werden. N2 - The use of bone-fixed implants, endoprosthesis and osteosythesis plates made of titanium are common treatements in medicine. Post-operative infections associated with biofilm-formation are a serious complication in surgery. Therefore, a focus in medical research deals with the developement of antiseptic surface coatings. This study describes the advancement of an electrochemical deposited surface coating made of calcium hydroxide on titanium, developed at “Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde” at University Hospital Würzburg. It was possible to combine the strong short-term antisepsis of calcium hydroxide with an effective long-term bactericide action by silber ions. KW - Calciumhydroxid KW - Hydroxylapatit KW - Beschichtungsanlage KW - Antisepsis KW - Silber KW - Osteosynthese KW - calciumhydroxide KW - surface coating KW - antisepis KW - silver KW - osteosynthesis Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-55114 ER - TY - JOUR A1 - Steinmann, Diana A1 - Paelecke-Habermann, Yvonne A1 - Geinitz, Hans A1 - Aschoff, Raimund A1 - Bayerl, Anja A1 - Bölling, Tobias A1 - Bosch, Elisabeth A1 - Bruns, Frank A1 - Eichenseder-Seiss, Ute A1 - Gerstein, Johanna A1 - Gharbi, Nadine A1 - Hagg, Juliane A1 - Hipp, Matthias A1 - Kleff, Irmgard A1 - Müller, Axel A1 - Schäfer, Christof A1 - Schleicher, Ursula A1 - Sehlen, Susanne A1 - Theodorou, Marilena A1 - Wypior, Hans-Joachim A1 - Zehentmayr, Franz A1 - van Oorschot, Birgitt A1 - Vordermark, Dirk T1 - Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases JF - BMC Cancer N2 - Background: Recently published results of quality of life (QoL) studies indicated different outcomes of palliative radiotherapy for brain metastases. This prospective multi-center QoL study of patients with brain metastases was designed to investigate which QoL domains improve or worsen after palliative radiotherapy and which might provide prognostic information. Methods: From 01/2007-01/2009, n=151 patients with previously untreated brain metastases were recruited at 14 centers in Germany and Austria. Most patients (82 %) received whole-brain radiotherapy. QoL was measured with the EORTC-QLQ-C15-PAL and brain module BN20 before the start of radiotherapy and after 3 months. Results: At 3 months, 88/142 (62 %) survived. Nine patients were not able to be followed up. 62 patients (70.5 % of 3-month survivors) completed the second set of questionnaires. Three months after the start of radiotherapy QoL deteriorated significantly in the areas of global QoL, physical function, fatigue, nausea, pain, appetite loss, hair loss, drowsiness, motor dysfunction, communication deficit and weakness of legs. Although the use of corticosteroid at 3 months could be reduced compared to pre-treatment (63 % vs. 37 %), the score for headaches remained stable. Initial QoL at the start of treatment was better in those alive than in those deceased at 3 months, significantly for physical function, motor dysfunction and the symptom scales fatigue, pain, appetite loss and weakness of legs. In a multivariate model, lower Karnofsky performance score, higher age and higher pain ratings before radiotherapy were prognostic of 3-month survival. Conclusions: Moderate deterioration in several QoL domains was predominantly observed three months after start of palliative radiotherapy for brain metastases. Future studies will need to address the individual subjective benefit or burden from such treatment. Baseline QoL scores before palliative radiotherapy for brain metastases may contain prognostic information. KW - breast cancer KW - brain tumours KW - survival KW - validation KW - symptoms KW - EORTC-QLQ-C15-PAL KW - EORTC-BN20 KW - whole-brain radiotherapy KW - partitioning analysis RPA KW - cancer patients KW - lung cancer KW - prognostic index KW - radiation oncology KW - clinical trials Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-135254 VL - 12 IS - 283 ER -